Friday, May 28, 2021 11:45:30 AM
Recent OCGN News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:59:25 PM
- Ocugen Appoints Rita Johnson-Greene to Chief Financial Officer • GlobeNewswire Inc. • 02/09/2026 12:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2026 01:12:02 PM
- Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common Stock • GlobeNewswire Inc. • 01/23/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/21/2026 10:29:15 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/21/2026 10:27:56 PM
- Ocugen shares slide after company prices $22.5 million equity raise • IH Market News • 01/21/2026 03:35:56 PM
- Ocugen, Inc. Announces Pricing of $22.5 Million Offering of Common Stock • GlobeNewswire Inc. • 01/21/2026 01:32:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 01:31:02 PM
- Ocugen Announces Positive Preliminary Phase 2 Data from OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration • GlobeNewswire Inc. • 01/15/2026 01:15:00 PM
- Ocugen to Host Webcast on Thursday, January 15 at 8:30 a.m. ET to Discuss OCU410 Phase 2 Clinical Trial Data • GlobeNewswire Inc. • 01/13/2026 12:00:00 PM
- Ocugen Announces Publication of Phase 1 GARDian1 Trial Results for OCU410ST Modifier Gene Therapy • GlobeNewswire Inc. • 01/12/2026 11:30:00 AM
- Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference • GlobeNewswire Inc. • 01/09/2026 12:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 10:20:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 10:20:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2025 10:17:28 PM
- Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit • GlobeNewswire Inc. • 12/10/2025 02:20:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 12/08/2025 04:45:46 PM
- Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference • GlobeNewswire Inc. • 11/20/2025 12:02:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/05/2025 02:41:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2025 12:30:48 PM
- Ocugen Provides Business Update with Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/05/2025 11:30:00 AM
- Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 10/23/2025 11:30:30 AM
- Ocugen to Present at Industry and Investor Conferences in October 2025 • GlobeNewswire Inc. • 10/02/2025 11:30:45 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 03:00:37 PM
UPDATE: Hydromer, Inc. Announces Expansion Into High-Speed Automated Coating and UV Cure Equipment Manufacturing • HYDI • Feb 10, 2026 10:58 AM
MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System • MWAI • Feb 10, 2026 8:45 AM
LaFleur Minerals Reports Assay Results Highlighting 2.05 g/t Au over 158.25 metres, Confirming Strong Gold Continuity at Swanson Gold Project • LFLRF • Feb 5, 2026 5:29 AM
DRCR Begins Rollout of New Business Model • DRCR • Feb 4, 2026 12:42 PM
BIO-PATH HOLDINGS ANNOUNCES "BPTH 2.0" STRATEGIC PIVOT ON WORLD CANCER DAY; ENGAGES LEGAL COUNSEL FOR REGULATION A OFFERING • BPTH • Feb 4, 2026 10:00 AM
Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • BLEG • Feb 4, 2026 9:07 AM
